MoCA Cognition Expands to the EU with New Innovation Hub in the Netherlands
The Canadian company chooses High Tech Campus Eindhoven to advance R&D for its digital cognitive health tools
Montreal-based MoCA Cognition, a leader in cognitive health technology, is making its first foray into Europe by establishing an innovation hub in the Netherlands, where it will advance its world-renowned digital assessment tools for neurodegenerative diseases. The company is known for its MoCA Test, an advanced diagnostic test that detects cognitive diseases like Alzheimer’s disease, Parkinson’s disease, brain tumors and more.
Located at High Tech Campus Eindhoven, MoCA Cognition’s innovation hub will leverage the Netherlands’ innovative life sciences & health and tech ecosystems, skilled workforce and R&D infrastructure to accelerate its research and product development, while positioning the company for future success in the global digital health market.
“This expansion to the Netherlands aligns with MoCA Cognition’s long-term growth strategy,” said Murray Gillies, PhD, Vice President of Science & Innovation at MoCA Cognition. “The new hub will accelerate the creation of AI-driven cognitive assessment products, ensuring the company stays at the forefront of cognitive health technology. This European presence provides the infrastructure needed to adapt to global market trends and maintain a competitive edge in the fast-evolving digital health sector.”
Leveraging Dutch expertise in AI, digital health
The Netherlands is globally recognized as a hub for cutting-edge innovation, particularly in artificial intelligence and digital health technologies. The country boasts a well-established ecosystem for R&D, supported by strong academic institutions, government initiatives and private-sector partnerships. It consistently ranks high for global innovation due to its well-developed infrastructure, research capabilities and collaborative environment.
MoCA Cognition’s presence at High Tech Campus Eindhoven will enable the company to collaborate with key technology partners and leading knowledge institutions like Eindhoven University of Technology, which has vast expertise in AI and cognitive technologies. MoCA Cognition aims to harness the region’s deep talent pool in AI, machine learning, data science and software development, all of which are crucial for advancing its digital cognitive health tools.
A conducive environment for innovation and growth
MoCA Cognition finds that the Netherlands’ regulatory environment is conducive to R&D and innovation. The country offers various incentives for R&D activities, which will support MoCA Cognition’s development of AI-driven cognitive assessment tools. Additionally, the Netherlands has a robust data privacy framework, ensuring that the company’s digital health products adhere to European privacy regulations, such as the EU General Data Protection Regulation (GDPR), further aligning with MoCA Cognition’s commitment to ethical and compliant technology development.
Moreover, the company recognizes the Netherlands as a key gateway to the European market. The country’s central location and excellent infrastructure will provide MoCA Cognition with a strong base for potential future growth into other European countries. Its new subsidiary will not only serve as an R&D hub, but also facilitate business development and partnership opportunities within the European Union. The Dutch ecosystem allows MoCA Cognition to meet the evolving needs of the global market, securing a competitive advantage in the rapidly growing field of digital health technologies.
Shaping the future of cognitive health with the Netherlands
MoCA Cognition is a valuable addition to the Netherlands’ efforts to address cognitive health and neurodegenerative diseases. The country has strong public-private partnerships (PPPs) such as the ABOARD project, which is led by Alzheimer Center Amsterdam and seeks to unite industry leaders and research institutions to drive preventative strategies for Alzheimer’s disease. As the Netherlands sharpens its focus on addressing neurogenerative diseases, MoCA Cognition’s expansion aligns seamlessly with broader national goals to advance research and develop solutions for cognitive impairments.
MoCA Cognition draws support from Invest in Holland Network
When it came time to expand to Europe, MoCA Cognition drew support from the Netherlands Foreign Investment Agency and Invest in Holland partner Brabant Development Agency to make a smooth transition into the Dutch innovation ecosystem. The company is now well-positioned to meet rising demands for innovation in the cognitive health field by collaborating with the Netherlands.
Source: BOM / Brabant is Bright
21 October 2024